HOME > COMMENTARY

COMMENTARY

BARKER ON DRUGS

February 18, 2002
Comarketing as a Marketing Strategy Option -1-

January 21, 2002
Comarketing as a Marketing Strategy Option -2-

January 21, 2002
Barker on Drugs (1)

January 14, 2002
Why Foreign-affiliated Companies Cannot Expand Their Market Share in Japan

July 9, 2001
< Special Contribution >What Are the Requirements for a Japanese Blockbuster Product? -2-

May 21, 2001
< Special Contribution >What Are the Requirements for a Japanese Blockbuster Product? -1-

May 21, 2001
Forecasting JapaneseDrug Industry Growth in FY2001

March 26, 2001
-1-

February 26, 2001
-2-

February 26, 2001
-1-

February 5, 2001
-2-

February 5, 2001
Advanced Technology and Segmentation of Companies

January 15, 2001
Don't Write Us Oldies Off!

January 15, 2001
Changing Japanese Heathcare Scene - Health Care Transition Leads Evaluation of Pharma Market -

January 15, 2001

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COLUMN

Strategic Talent Acquisition in the Japanese Life Sciences Sector: Your Market Intelligence Briefing

By Philip Carrigan

Focus: How to Get the Talent You Need in a Tough MarketThe Japanese life sciences sector presents a challenging landscape for global companies. To succeed, you must move beyond reactive hiring and adopt a truly strategic talent acquisition model. Our…